Literature DB >> 16583245

Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathway.

M H A Malik1, A Bayat, F Jury, W E R Ollier, P R Kay.   

Abstract

The OPG/RANK/RANKL system has been implicated in the biological cascade of events initiated by particulate wear debris and bacterial infection resulting in periprosthetic bone loss around total hip arthroplasties (THA). Individual responses to such stimuli may be dictated by genetic variation caused by single nucleotide polymorphisms (SNPs). Case control study of the osteoprotegerin and RANK genes for possible association with deep sepsis or aseptic loosening. All patients were Caucasian and had had a cemented Charnley THA and polyethylene acetabular cup. Cases consisted of 91 patients with early aseptic loosening and 71 patients with deep infection. Controls were 150 clinically and radiologically well-fixed THAs. DNA samples were genotyped using Taqman allelic discrimination. The A allele (p<0.001) and genotype A/A (p<0.001) for the OPG-163 SNP were associated with aseptic failure. Additionally, the RANK +575 (C/T SNP) T allele (p=0.004) and T/T genotype (p=0.008) frequencies were associated with aseptic failure. Comparing the septic group with the controls, the frequency of the A allele (p<0.001) and the genotype A/A (p<0.001) for the OPG-163 SNP were statistically significant. Aseptic loosening and deep infection of THA may be under the influence of susceptibility genes. SNP markers may serve as predictors of implant survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583245      PMCID: PMC2532089          DOI: 10.1007/s00264-006-0074-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  21 in total

Review 1.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

2.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.

Authors:  P Honore; N M Luger; M A Sabino; M J Schwei; S D Rogers; D B Mach; P F O'keefe; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Evaluation of the role of RANK and OPG genes in Paget's disease of bone.

Authors:  W Wuyts; L Van Wesenbeeck; A Morales-Piga; S Ralston; L Hocking; F Vanhoenacker; R Westhovens; L Verbruggen; D Anderson; A Hughes; W Van Hul
Journal:  Bone       Date:  2001-01       Impact factor: 4.398

Review 5.  The basic science of periprosthetic osteolysis.

Authors:  M J Archibeck; J J Jacobs; K A Roebuck; T T Glant
Journal:  Instr Course Lect       Date:  2001

Review 6.  The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.

Authors:  D R Haynes; T N Crotti; A E Potter; M Loric; G J Atkins; D W Howie; D M Findlay
Journal:  J Bone Joint Surg Br       Date:  2001-08

7.  In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.

Authors:  Lisa M Childs; Eleftherios P Paschalis; Lianping Xing; William C Dougall; Dirk Anderson; Adele L Boskey; J Edward Puzas; Randy N Rosier; Regis J O'Keefe; Brendan F Boyce; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2002-02       Impact factor: 6.741

8.  Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.

Authors:  Bente L Langdahl; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

9.  Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis.

Authors:  Hioryuki Ohmori; Yoshio Makita; Makiko Funamizu; Kenzou Hirooka; Takayuki Hosoi; Hajime Orimo; Takao Suzuki; Katsunori Ikari; Toshiaki Nakajima; Ituro Inoue; Akira Hata
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

10.  Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.

Authors:  B Arko; J Prezelj; R Komel; A Kocijancic; P Hudler; J Marc
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

View more
  8 in total

Review 1.  Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?

Authors:  Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

2.  Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation?

Authors:  Ryan M Baxter; Theresa A Freeman; Steven M Kurtz; Marla J Steinbeck
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

Review 3.  Influence of single nucleotide polymorphisms (SNPs) in genetic susceptibility towards periprosthetic osteolysis.

Authors:  Supriya Jagga; Ashish Ranjan Sharma; Manojit Bhattacharya; Chiranjib Chakraborty; Sang-Soo Lee
Journal:  Genes Genomics       Date:  2019-07-16       Impact factor: 1.839

4.  Pressurized carbon dioxide lavage reduces the incidence of a radiolucent line around the tibial component two years after total knee arthroplasty.

Authors:  Ryo Sasaki; Masaki Nagashima; Toshiro Otani; Yoshifumi Okada; Noriyuki Aibara; Kenichiro Takeshima; Ken Ishii
Journal:  J Orthop Surg Res       Date:  2022-07-15       Impact factor: 2.677

5.  Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study.

Authors:  Jiri Gallo; Frantisek Mrazek; Martin Petrek
Journal:  BMC Med Genet       Date:  2009-10-27       Impact factor: 2.103

6.  The 2018 Otto Aufranc Award: How Does Genome-wide Variation Affect Osteolysis Risk After THA?

Authors:  Scott J MacInnes; Konstantinos Hatzikotoulas; Anne Marie Fenstad; Karan Shah; Lorraine Southam; Ioanna Tachmazidou; Geir Hallan; Hårvard Dale; Kalliope Panoutsopoulou; Ove Furnes; Eleftheria Zeggini; J Mark Wilkinson
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

Review 7.  Risk factors for revision of primary total hip arthroplasty: a systematic review.

Authors:  Julian Jz Prokopetz; Elena Losina; Robin L Bliss; John Wright; John A Baron; Jeffrey N Katz
Journal:  BMC Musculoskelet Disord       Date:  2012-12-15       Impact factor: 2.362

8.  Variation in the IL1B, TNF and IL6 genes and individual susceptibility to prosthetic joint infection.

Authors:  Anna Stahelova; Frantisek Mrazek; Matej Smizansky; Martin Petrek; Jiri Gallo
Journal:  BMC Immunol       Date:  2012-05-08       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.